ArticleFrontiers in oncology2024

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec's University teaching hospitals.

Valérie Labrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.